Northeast Financial Consultants Has Trimmed Its Intl Flavors& Fragrances (IFF) Holding by $509,200 as Stock Price Rose; Rock Springs Capital Management LP Raised Position in Clovis Oncology (CLVS) by $4.37 Million as Market Valuation Declined

December 17, 2017 - By Dolores Ford

Rock Springs Capital Management Lp increased its stake in Clovis Oncology Inc (CLVS) by 25.47% based on its latest 2017Q2 regulatory filing with the SEC. Rock Springs Capital Management Lp bought 47,000 shares as the company’s stock declined 20.61% while stock markets rallied. The hedge fund held 231,500 shares of the health care company at the end of 2017Q2, valued at $21.68M, up from 184,500 at the end of the previous reported quarter. Rock Springs Capital Management Lp who had been investing in Clovis Oncology Inc for a number of months, seems to be bullish on the $3.14 billion market cap company. The stock decreased 0.02% or $0.01 during the last trading session, reaching $64.13. About 2.03M shares traded or 52.22% up from the average. Clovis Oncology, Inc. (NASDAQ:CLVS) has risen 282.71% since December 17, 2016 and is uptrending. It has outperformed by 266.01% the S&P500.

Northeast Financial Consultants Inc decreased its stake in Intl Flavors& Fragrances (IFF) by 14.56% based on its latest 2017Q2 regulatory filing with the SEC. Northeast Financial Consultants Inc sold 3,800 shares as the company’s stock rose 10.17% with the market. The institutional investor held 22,305 shares of the basic industries company at the end of 2017Q2, valued at $3.01M, down from 26,105 at the end of the previous reported quarter. Northeast Financial Consultants Inc who had been investing in Intl Flavors& Fragrances for a number of months, seems to be less bullish one the $12.18B market cap company. The stock increased 1.68% or $2.54 during the last trading session, reaching $154.17. About 526,020 shares traded or 86.01% up from the average. International Flavors & Fragrances Inc. (NYSE:IFF) has risen 5.32% since December 17, 2016 and is uptrending. It has underperformed by 11.38% the S&P500.

Among 16 analysts covering Internationa Flavors & Fragrances (NYSE:IFF), 7 have Buy rating, 1 Sell and 8 Hold. Therefore 44% are positive. Internationa Flavors & Fragrances had 31 analyst reports since August 11, 2015 according to SRatingsIntel. UBS maintained it with “Buy” rating and $166 target in Tuesday, November 7 report. The rating was maintained by KeyBanc Capital Markets on Monday, October 16 with “Overweight”. The stock has “Buy” rating by UBS on Thursday, February 23. Stifel Nicolaus maintained it with “Hold” rating and $121 target in Tuesday, November 8 report. The firm earned “Hold” rating on Thursday, February 11 by Deutsche Bank. The firm has “Hold” rating given on Thursday, August 10 by Deutsche Bank. The company was downgraded on Monday, January 25 by Stifel Nicolaus. As per Wednesday, May 11, the company rating was maintained by Deutsche Bank. The rating was downgraded by BNP Paribas on Friday, January 6 to “Neutral”. Stifel Nicolaus maintained it with “Hold” rating and $136.0 target in Monday, September 18 report.

Northeast Financial Consultants Inc, which manages about $2.86B and $253.75M US Long portfolio, upped its stake in Allergan Inc by 1,328 shares to 3,906 shares, valued at $950,000 in 2017Q2, according to the filing. It also increased its holding in Energy Transfer Partners Lp (NYSE:ETP) by 38,608 shares in the quarter, for a total of 77,758 shares, and has risen its stake in Vanguard Whitehall Fd.

Since August 1, 2017, it had 11 insider buys, and 4 insider sales for $76.69 million activity. MIRZAYANTZ NICOLAS had sold 1,233 shares worth $169,192. On Wednesday, August 2 the insider Fortanet Francisco sold $40,308. Shares for $411,660 were sold by Chwat Anne.

Analysts await International Flavors & Fragrances Inc. (NYSE:IFF) to report earnings on February, 21. They expect $1.30 EPS, up 6.56% or $0.08 from last year’s $1.22 per share. IFF’s profit will be $102.67M for 29.65 P/E if the $1.30 EPS becomes a reality. After $1.47 actual EPS reported by International Flavors & Fragrances Inc. for the previous quarter, Wall Street now forecasts -11.56% negative EPS growth.

Investors sentiment decreased to 0.79 in Q2 2017. Its down 0.21, from 1 in 2017Q1. It dropped, as 41 investors sold IFF shares while 161 reduced holdings. 46 funds opened positions while 113 raised stakes. 54.06 million shares or 2.72% less from 55.57 million shares in 2017Q1 were reported. Stratos Wealth Prtnrs Limited invested in 0.02% or 2,826 shares. Aviva Public Ltd Co invested 0.04% in International Flavors & Fragrances Inc. (NYSE:IFF). Moreover, Cap Research Investors has 0.16% invested in International Flavors & Fragrances Inc. (NYSE:IFF) for 3.69M shares. Copeland Cap Lc accumulated 0.97% or 109,647 shares. Northwestern Mutual Wealth Com invested 0% of its portfolio in International Flavors & Fragrances Inc. (NYSE:IFF). Moreover, Hsbc Public Limited Co has 0.03% invested in International Flavors & Fragrances Inc. (NYSE:IFF) for 102,132 shares. Employees Retirement Sys Of Ohio holds 0.02% or 32,635 shares. Burns J W & New York holds 0.12% or 3,260 shares. Arrow Financial owns 16,186 shares for 0.52% of their portfolio. Mastrapasqua Asset Mngmt Incorporated reported 0.26% of its portfolio in International Flavors & Fragrances Inc. (NYSE:IFF). Cutler Counsel Ltd Co holds 0.06% of its portfolio in International Flavors & Fragrances Inc. (NYSE:IFF) for 1,900 shares. Covington Mngmt accumulated 32,088 shares. Cubist Systematic Strategies Lc invested in 0.02% or 2,429 shares. Cleararc Capital holds 0.04% or 1,942 shares in its portfolio. Wfg Advsr Ltd Partnership stated it has 0.01% in International Flavors & Fragrances Inc. (NYSE:IFF).

Since August 4, 2017, it had 0 insider purchases, and 4 sales for $2.12 million activity. 18,450 shares were sold by BLAIR JAMES C, worth $1.45M on Friday, August 4.

Rock Springs Capital Management Lp, which manages about $319.00M and $1.98B US Long portfolio, decreased its stake in Amarin Corp Plc (NASDAQ:AMRN) by 751,200 shares to 4.25M shares, valued at $17.13 million in 2017Q2, according to the filing. It also reduced its holding in Ra Pharmaceuticals Inc by 188,959 shares in the quarter, leaving it with 600,000 shares, and cut its stake in Allergan Plc.

Investors sentiment decreased to 1.81 in Q2 2017. Its down 0.66, from 2.47 in 2017Q1. It dropped, as 33 investors sold CLVS shares while 56 reduced holdings. 74 funds opened positions while 87 raised stakes. 46.46 million shares or 12.58% more from 41.27 million shares in 2017Q1 were reported. Envestnet Asset stated it has 433 shares. Teacher Retirement Sys Of Texas holds 0% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS) for 3,211 shares. Shell Asset Mgmt invested in 7,680 shares. Kazazian Asset Management Llc owns 11,264 shares or 1.6% of their US portfolio. 5,900 were reported by Ellington Mngmt Gru Ltd Liability Co. Harbourvest Prtnrs Ltd Liability Co stated it has 0.86% in Clovis Oncology, Inc. (NASDAQ:CLVS). Gotham Asset Mngmt Limited Liability reported 0% stake. Eam Lc holds 0.65% or 42,294 shares in its portfolio. Swiss Commercial Bank reported 0.01% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). Products Prns Ltd Com invested 0.07% in Clovis Oncology, Inc. (NASDAQ:CLVS). Palo Alto Invsts Ltd Liability invested in 3.33M shares. The New York-based Consonance Capital Lp has invested 6.01% in Clovis Oncology, Inc. (NASDAQ:CLVS). Insight Rech & Mgmt accumulated 8,757 shares. Sphera Funds Mgmt Limited has 1.48% invested in Clovis Oncology, Inc. (NASDAQ:CLVS). Point72 Asset Management Ltd Partnership accumulated 30,000 shares.